Literature DB >> 6616236

Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. II. Pharmacological and behavioral study.

F Gonon, M Buda, G De Simoni, J F Pujol.   

Abstract

Differential pulse voltammetry used in combination with electrochemically treated carbon fiber electrodes allowed us to detect catechols in the locus coeruleus (LC) of conscious freely moving rats. A micromanipulator cemented on the rat skull was designed in order to implant carbon fiber electrodes without anesthesia. Voltammograms were recorded every 2 min for 5 h. After the in vivo experiments electrodes were tested in 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylglycol (DOPEG) and noradrenaline (NA) solutions. The catechol peak recorded from LC was suppressed by pargyline treatment and slightly reappeared after inhibition of the NA reuptake by desipramine (DMI). This reappearing signal was attributed to NA and estimated at a concentration 50 nM NA. Various drug treatments (piperoxane, haloperidol, clonidine, DMI and reserpine) allowed us to further support the conclusion of part I of this study: the catechol peak recorded from LC is mainly due to DOPAC synthesized by LC noradrenergic neurons. This DOPAC signal corresponded to a DOPAC concentration which reached 23 microM when the whole active part of the electrode was implanted in the LC. In addition to this pharmacological study, data from stress experiments pointed out a striking parallel between the variations of the DOPAC signal and those of the activity of LC noradrenergic neurons as revealed by reported electrophysiological studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616236     DOI: 10.1016/0006-8993(83)90845-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  GABA mimetics increase extracellular DOPAC (as measured by in vivo voltammetry) in the rat locus coeruleus.

Authors:  B Scatton; A Serrano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

2.  3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.

Authors:  O Boulat; P Waldmeier; L Maitre
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.

Authors:  T Dennis; O Curet; T Nishikawa; B Scatton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

4.  Local cerebral blood flow in gently restrained rats: effects of propranolol and diazepam.

Authors:  F Lasbennes; J Seylaz
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Effect of short-term swimming stress and diazepam on 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the caudate nucleus: an in vivo voltammetric study.

Authors:  M Ikeda; T Nagatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

6.  The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study.

Authors:  E Badoer; H Würth; D Türck; F Qadri; K Itoi; P Dominiak; T Unger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

7.  Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N. raphe dorsalis and the Locus coeruleus of the rat.

Authors:  H W Clement; D Gemsa; W Wesemann
Journal:  J Neural Transm Gen Sect       Date:  1992

8.  Neuroendocrine stress responses predict catecholamine-dependent working memory-related dorsolateral prefrontal cortex activity.

Authors:  Dennis Hernaus; Conny W E M Quaedflieg; Jan Stefan Offermann; Marta M Casales Santa; Thérèse van Amelsvoort
Journal:  Soc Cogn Affect Neurosci       Date:  2018-01-01       Impact factor: 3.436

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.